{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:59:34Z","timestamp":1779915574314,"version":"3.53.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03017-9","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T20:02:01Z","timestamp":1707422521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of immune-related regulatory networks and diagnostic biomarkers in thyroid eye disease"],"prefix":"10.1007","volume":"44","author":[{"given":"Xiangmei","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"issue":"4","key":"3017_CR1","first-page":"343","volume":"119","author":"J Szelog","year":"2022","unstructured":"Szelog J, Swanson H, Sniegowski MC, Lyon DB (2022) Thyroid eye disease. Mo Med 119(4):343\u2013350","journal-title":"Mo Med"},{"issue":"Suppl 1","key":"3017_CR2","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1210\/clinem\/dgac252","volume":"107","author":"G Barbesino","year":"2022","unstructured":"Barbesino G, Salvi M, Freitag SK (2022) Future projections in thyroid eye disease. J Clin Endocrinol Metab 107(Suppl 1):S47\u2013S56","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3017_CR3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/imj.15067","volume":"52","author":"AJH Hall","year":"2022","unstructured":"Hall AJH, Topliss DJ (2022) Medical and surgical treatment of thyroid eye disease. Intern Med J 52(1):14\u201320","journal-title":"Intern Med J"},{"issue":"6","key":"3017_CR4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/01676830802414939","volume":"27","author":"MP Mourits","year":"2008","unstructured":"Mourits MP (2008) Prevention of graves\u2019 orbitopathy: early diagnosis of thyroid-associated orbitopathy in Graves\u2019 disease. Orbit 27(6):399\u2013400","journal-title":"Orbit"},{"issue":"2","key":"3017_CR5","first-page":"89","volume":"10","author":"N Paunkovic","year":"2007","unstructured":"Paunkovic N, Paunkovic J (2007) The diagnostic criteria of Graves\u2019 disease and especially the thyrotropin receptor antibody; our own experience. Hell J Nucl Med 10(2):89\u201394","journal-title":"Hell J Nucl Med"},{"key":"3017_CR6","doi-asserted-by":"crossref","first-page":"920716","DOI":"10.3389\/fmed.2022.920716","volume":"9","author":"X Huang","year":"2022","unstructured":"Huang X, Ju L, Li J, He L, Tong F, Liu S, Li P, Zhang Y, Wang X, Yang Z, Xiong J, Wang L, Zhao X, He W, Huang Y, Ge Z, Yao X, Yang W, Wei R (2022) An intelligent diagnostic system for thyroid-associated ophthalmopathy based on facial images. Front Med (Lausanne) 9:920716","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"3017_CR7","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1111\/jcmm.16605","volume":"25","author":"Z Chen","year":"2021","unstructured":"Chen Z, Chen Z, Wang J, Zhang M, Wang X, Cuomu D, Shi B, Wang Y (2021) Leptin receptor is a key gene involved in the immunopathogenesis of thyroid-associated ophthalmopathy. J Cell Mol Med 25(12):5799\u20135810","journal-title":"J Cell Mol Med"},{"issue":"6","key":"3017_CR8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamaophthalmol.2018.0806","volume":"136","author":"G Rotondo Dottore","year":"2018","unstructured":"Rotondo Dottore G, Torregrossa L, Caturegli P, Ionni I, Sframeli A, Sabini E, Menconi F, Piaggi P, Sellari-Franceschini S, Nardi M, Latrofa F, Vitti P, Marcocci C, Basolo F, Marino M (2018) Association of T and B cells infiltrating orbital tissues with clinical features of graves orbitopathy. JAMA Ophthalmol 136(6):613\u2013619","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"3017_CR9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2249.2005.02824.x","volume":"141","author":"TJ Smith","year":"2005","unstructured":"Smith TJ (2005) Insights into the role of fibroblasts in human autoimmune diseases. Clin Exp Immunol 141(3):388\u2013397","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"3017_CR10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/thy.2011.0248","volume":"22","author":"B Ujhelyi","year":"2012","unstructured":"Ujhelyi B, Gogolak P, Erdei A, Nagy V, Balazs E, Rajnavolgyi E, Berta A, Nagy EV (2012) Graves\u2019 orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines. Thyroid 22(4):407\u2013414","journal-title":"Thyroid"},{"issue":"2","key":"3017_CR11","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2008.03219.x","volume":"69","author":"MH Chen","year":"2008","unstructured":"Chen MH, Chen MH, Liao SL, Chang TC, Chuang LM (2008) Role of macrophage infiltration in the orbital fat of patients with Graves\u2019 ophthalmopathy. Clin Endocrinol (Oxf) 69(2):332\u2013337","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"3017_CR12","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1210\/jc.2007-2190","volume":"93","author":"AK Huber","year":"2008","unstructured":"Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y (2008) Interleukin (IL)-23 receptor is a major susceptibility gene for Graves\u2019 ophthalmopathy: the IL-23\/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 93(3):1077\u20131081","journal-title":"J Clin Endocrinol Metab"},{"key":"3017_CR13","doi-asserted-by":"crossref","first-page":"1118391","DOI":"10.3389\/fgene.2023.1118391","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen S, Diao J, Yue Z, Wei R (2023) Identification and validation of ferroptosis-related genes and immune cell infiltration in thyroid associated ophthalmopathy. Front Genet 14:1118391","journal-title":"Front Genet"},{"key":"3017_CR14","doi-asserted-by":"crossref","first-page":"1203120","DOI":"10.3389\/fendo.2023.1203120","volume":"14","author":"C Xiong","year":"2023","unstructured":"Xiong C, Wang Y, Li Y, Yu J, Wu S, Wu L, Zhang B, Chen Y, Gan P, Liao H (2023) Identification of optimal feature genes in patients with thyroid associated ophthalmopathy and their relationship with immune infiltration: a bioinformatics analysis. Front Endocrinol (Lausanne) 14:1203120","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"3017_CR15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41433-018-0279-9","volume":"33","author":"Y Huang","year":"2019","unstructured":"Huang Y, Fang S, Li D, Zhou H, Li B, Fan X (2019) The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy. Eye (Lond) 33(2):176\u2013182","journal-title":"Eye (Lond)"},{"issue":"5","key":"3017_CR16","first-page":"e368","volume":"170","author":"D Gonnella","year":"2019","unstructured":"Gonnella D (2019) The Th1 chemokine MIG in Graves\u2019 ophthalmopathy. Clin Ter 170(5):e368\u2013e372","journal-title":"Clin Ter"},{"issue":"5","key":"3017_CR17","first-page":"911","volume":"17","author":"N Xia","year":"2006","unstructured":"Xia N, Zhou S, Liang Y, Xiao C, Shen H, Pan H, Deng H, Wang N, Li QQ (2006) CD4+ T cells and the Th1\/Th2 imbalance are implicated in the pathogenesis of Graves\u2019 ophthalmopathy. Int J Mol Med 17(5):911\u2013916","journal-title":"Int J Mol Med"},{"key":"3017_CR18","first-page":"251584142110277","volume":"13","author":"CJ Men","year":"2021","unstructured":"Men CJ, Kossler AL, Wester ST (2021) Updates on the understanding and management of thyroid eye disease. Ther Adv Ophthalmol 13:25158414211027760","journal-title":"Ther Adv Ophthalmol"},{"key":"3017_CR19","doi-asserted-by":"crossref","first-page":"648732","DOI":"10.3389\/fendo.2021.648732","volume":"12","author":"S Fang","year":"2021","unstructured":"Fang S, Lu Y, Huang Y, Zhou H, Fan X (2021) Mechanisms that underly T cell immunity in Graves\u2019 orbitopathy. Front Endocrinol (Lausanne) 12:648732","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3017_CR20","doi-asserted-by":"crossref","first-page":"754386","DOI":"10.3389\/fphar.2021.754386","volume":"12","author":"G Elia","year":"2021","unstructured":"Elia G, Fallahi P, Ragusa F, Paparo SR, Mazzi V, Benvenga S, Antonelli A, Ferrari SM (2021) Precision medicine in Graves\u2019 disease and ophthalmopathy. Front Pharmacol 12:754386","journal-title":"Front Pharmacol"},{"key":"3017_CR21","doi-asserted-by":"crossref","first-page":"908034","DOI":"10.3389\/fimmu.2022.908034","volume":"13","author":"AD Courey-Ghaouzi","year":"2022","unstructured":"Courey-Ghaouzi AD, Kleberg L, Sundling C (2022) Alternative B cell differentiation during infection and inflammation. Front Immunol 13:908034","journal-title":"Front Immunol"},{"issue":"3","key":"3017_CR22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/01658107.2015.1039140","volume":"39","author":"RA Ostrowski","year":"2015","unstructured":"Ostrowski RA, Bussey MR, Shayesteh Y, Jay WM (2015) Rituximab in the treatment of thyroid eye disease: a review. Neuro Ophthalmol (Aeolus Press) 39(3):109\u2013115","journal-title":"Neuro Ophthalmol (Aeolus Press)"},{"issue":"2","key":"3017_CR23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/EJE-22-0247","volume":"187","author":"HO Ueland","year":"2022","unstructured":"Ueland HO, Ueland G, L\u00f8v\u00e5s K, Breivk LE, Thrane AS, Meling Stokland AE, R\u00f8dahl E, Husebye ES (2022) Novel inflammatory biomarkers in thyroid eye disease. Eur J Endocrinol 187(2):293\u2013300","journal-title":"Eur J Endocrinol"},{"key":"3017_CR24","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1007\/s10792-023-02742-x","volume":"43","author":"N Yuksel","year":"2023","unstructured":"Yuksel N, Saritas O, Yuksel E (2023) Effect of thyroid hormone status on complete blood cell count-derived inflammatory biomarkers in patients with moderate-to-severe Graves\u2019 ophthalmopathy. Int Ophthalmol 43:3355\u20133362. https:\/\/doi.org\/10.1007\/s10792-023-02742-x","journal-title":"Int Ophthalmol"},{"issue":"4","key":"3017_CR25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"MJ McGeachy","year":"2019","unstructured":"McGeachy MJ, Cua DJ, Gaffen SL (2019) The IL-17 family of cytokines in health and disease. Immunity 50(4):892\u2013906","journal-title":"Immunity"},{"issue":"14","key":"3017_CR26","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1167\/iovs.16-20199","volume":"57","author":"S Fang","year":"2016","unstructured":"Fang S, Huang Y, Zhong S, Zhang Y, Liu X, Wang Y, Gu P, Zhou H, Fan X (2016) IL-17A promotes RANTES expression, but not IL-16, in orbital fibroblasts via CD40-CD40L combination in thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci 57(14):6123\u20136133","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3017_CR27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fphar.2017.00460","volume":"8","author":"P Li","year":"2017","unstructured":"Li P, Zheng Y, Chen X (2017) Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics. Front Pharmacol 8:460","journal-title":"Front Pharmacol"},{"key":"3017_CR28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cyto.2016.08.035","volume":"101","author":"E Varfolomeev","year":"2018","unstructured":"Varfolomeev E, Vucic D (2018) Intracellular regulation of TNF activity in health and disease. Cytokine 101:26\u201332","journal-title":"Cytokine"},{"issue":"6","key":"3017_CR29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.humimm.2004.02.033","volume":"65","author":"T Bednarczuk","year":"2004","unstructured":"Bednarczuk T, Hiromatsu Y, Seki N, P\u0142oski R, Fukutani T, Kury\u0142owicz A, Jazdzewski K, Chojnowski K, Itoh K, Nauman J (2004) Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves\u2019 ophthalmopathy. Hum Immunol 65(6):632\u2013639","journal-title":"Hum Immunol"},{"issue":"1","key":"3017_CR30","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41467-022-28341-5","volume":"13","author":"H G\u00f6\u00f6s","year":"2022","unstructured":"G\u00f6\u00f6s H, Kinnunen M, Salokas K, Tan Z, Liu X, Yadav L, Zhang Q, Wei GH, Varjosalo M (2022) Human transcription factor protein interaction networks. Nat Commun 13(1):766","journal-title":"Nat Commun"},{"issue":"10","key":"3017_CR31","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1167\/iovs.15-17503","volume":"56","author":"S Kunst","year":"2015","unstructured":"Kunst S, Wolloscheck T, Kelleher DK, Wolfrum U, Sargsyan SA, Iuvone PM, Baba K, Tosini G, Spessert R (2015) Pgc-1\u03b1 and Nr4a1 are target genes of circadian melatonin and dopamine release in murine retina. Invest Ophthalmol Vis Sci 56(10):6084\u20136094","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7749","key":"3017_CR32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41586-019-0979-8","volume":"567","author":"X Liu","year":"2019","unstructured":"Liu X, Wang Y, Lu H, Li J, Yan X, Xiao M, Hao J, Alekseev A, Khong H, Chen T, Huang R, Wu J, Zhao Q, Wu Q, Xu S, Wang X, Jin W, Yu S, Wang Y, Wei L, Wang A, Zhong B, Ni L, Liu X, Nurieva R, Ye L, Tian Q, Bian XW, Dong C (2019) Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction. Nature 567(7749):525\u2013529","journal-title":"Nature"},{"issue":"1","key":"3017_CR33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41392-021-00867-y","volume":"7","author":"X Han","year":"2022","unstructured":"Han X, Xu T, Ding C, Wang D, Yao G, Chen H, Fang Q, Hu G, Sun L (2022) Neuronal NR4A1 deficiency drives complement-coordinated synaptic stripping by microglia in a mouse model of lupus. Signal Transduct Target Ther 7(1):50","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3017_CR34","doi-asserted-by":"crossref","first-page":"e12701","DOI":"10.1111\/sji.12701","volume":"88","author":"M Liu","year":"2018","unstructured":"Liu M, Zhao X, Ma Y, Zhou Y, Deng M, Ma Y (2018) Transcription factor c-Maf is essential for IL-10 gene expression in B cells. Scand J Immunol 88(3):e12701","journal-title":"Scand J Immunol"},{"issue":"5","key":"3017_CR35","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3390\/ijms21051664","volume":"21","author":"E Havis","year":"2020","unstructured":"Havis E, Duprez D (2020) EGR1 transcription factor is a multifaceted regulator of matrix production in tendons and other connective tissues. Int J Mol Sci 21(5):1664","journal-title":"Int J Mol Sci"},{"key":"3017_CR36","doi-asserted-by":"crossref","first-page":"108072","DOI":"10.1016\/j.intimp.2021.108072","volume":"99","author":"YB Chu","year":"2021","unstructured":"Chu YB, Li J, Jia P, Cui J, Zhang R, Kang X, Lv M, Zhang S (2021) Irf1- and Egr1-activated transcription plays a key role in macrophage polarization: a multiomics sequencing study with partial validation. Int Immunopharmacol 99:108072","journal-title":"Int Immunopharmacol"},{"key":"3017_CR37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fcimb.2018.00287","volume":"8","author":"HT Hop","year":"2018","unstructured":"Hop HT, Arayan LT, Huy TXN, Reyes AWB, Vu SH, Min W, Lee HJ, Rhee MH, Chang HH, Kim S (2018) The key role of c-Fos for immune regulation and bacterial dissemination in Brucella infected macrophage. Front Cell Infect Microbiol 8:287","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"3017_CR38","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00018-013-1407-0","volume":"71","author":"M Donadelli","year":"2014","unstructured":"Donadelli M, Dando I, Fiorini C, Palmieri M (2014) UCP2, a mitochondrial protein regulated at multiple levels. Cell Mol Life Sci 71(7):1171\u20131190","journal-title":"Cell Mol Life Sci"},{"issue":"1 Supplement","key":"3017_CR39","doi-asserted-by":"crossref","first-page":"64.11","DOI":"10.4049\/jimmunol.210.Supp.64.11","volume":"210","author":"S Choi","year":"2023","unstructured":"Choi S, Mehrotra S (2023) UCP2 deficiency renders Th1\/2 pathogenic phenotype to CD4 + T cells. J Immunol 210(1 Supplement):64.11","journal-title":"J Immunol"},{"issue":"4","key":"3017_CR40","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.bbadis.2017.01.019","volume":"1863","author":"A Smorodchenko","year":"2017","unstructured":"Smorodchenko A, Schneider S, Rupprecht A, Hilse K, Sasgary S, Zeitz U, Erben RG, Pohl EE (2017) UCP2 up-regulation within the course of autoimmune encephalomyelitis correlates with T-lymphocyte activation. Biochim Biophys Acta Mol Basis Dis 1863(4):1002\u20131012","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"3017_CR41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12031-016-0728-5","volume":"58","author":"CJ Barnstable","year":"2016","unstructured":"Barnstable CJ, Reddy R, Li H, Horvath TL (2016) Mitochondrial uncoupling protein 2 (UCP2) regulates retinal ganglion cell number and survival. J Mol Neurosci MN 58(4):461\u2013469","journal-title":"J Mol Neurosci MN"},{"issue":"11","key":"3017_CR42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/iovs.61.11.20","volume":"61","author":"MJ Simcoe","year":"2020","unstructured":"Simcoe MJ, Khawaja AP, Mahroo OA, Hammond CJ, Hysi PG (2020) The role of chromosome x in intraocular pressure variation and sex-specific effects. Invest Ophthalmol Vis Sci 61(11):20","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"3017_CR43","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/rheumatology\/keq456","volume":"50","author":"M Molokhia","year":"2011","unstructured":"Molokhia M, Fanciulli M, Petretto E, Patrick AL, McKeigue P, Roberts AL, Vyse TJ, Aitman TJ (2011) FCGR3B copy number variation is associated with systemic lupus erythematosus risk in Afro-Caribbeans. Rheumatology (Oxford) 50(7):1206\u20131210","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3017_CR44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/dna.2020.5789","volume":"40","author":"J Cui","year":"2021","unstructured":"Cui J, Wang L, Zhong W, Chen Z, Chen J, Yang H, Liu G (2021) Development and validation of epigenetic signature predict survival for patients with laryngeal squamous cell carcinoma. DNA Cell Biol 40(2):247\u2013264","journal-title":"DNA Cell Biol"},{"key":"3017_CR45","doi-asserted-by":"crossref","first-page":"108864","DOI":"10.1016\/j.biopha.2019.108864","volume":"114","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Zheng B, Meng S, Xu Y, Guo J, Chen LJ, Xiao J, Zhang W, Tan ZR, Tang J, Chen L, Chen Y (2019) Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy. Biomed Pharmacother 114:108864","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"3017_CR46","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.18632\/aging.204110","volume":"14","author":"Y Xiang","year":"2022","unstructured":"Xiang Y, Liu H, Hu H, Li LW, Zong QB, Wu TW, Li XY, Fang SQ, Liu YW, Zhan Y, Wang H, Lu ZX (2022) LINC00094\/miR-19a-3p\/CYP19A1 axis affects the sensitivity of ER positive breast cancer cells to Letrozole through EMT pathway. Aging (Albany NY) 14(11):4755\u20134768","journal-title":"Aging (Albany NY)"},{"key":"3017_CR47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbrc.2022.04.052","volume":"610","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Liang M, Wang B, Kang L, Yuan Y, Mao Y, Wang S (2022) GALNT12 is associated with the malignancy of glioma and promotes glioblastoma multiforme in vitro by activating Akt signaling. Biochem Biophys Res Commun 610:99\u2013106","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3017_CR48","first-page":"222","volume":"75","author":"AP Weetman","year":"1989","unstructured":"Weetman AP, Cohen S, Gatter KC, Fells P, Shine B (1989) Immunohistochemical analysis of the retrobulbar tissues in Graves\u2019 ophthalmopathy. Clin Exp Immunol 75(2):222\u2013227","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"3017_CR49","first-page":"114","volume":"2","author":"JM Taylor","year":"1989","unstructured":"Taylor JM, Fahey JL, Detels R, Giorgi JV (1989) CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr 2(2):114\u2013124","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"3017_CR50","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1172\/JCI117289","volume":"93","author":"B Grubeck-Loebenstein","year":"1994","unstructured":"Grubeck-Loebenstein B, Trieb K, Sztankay A, Holter W, Anderl H, Wick G (1994) Retrobulbar T cells from patients with Graves\u2019 ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. J Clin Invest 93(6):2738\u20132743","journal-title":"J Clin Invest"},{"issue":"10","key":"3017_CR51","doi-asserted-by":"crossref","first-page":"102369","DOI":"10.1016\/j.autrev.2019.102369","volume":"18","author":"P Di Benedetto","year":"2019","unstructured":"Di Benedetto P, Ruscitti P, Vadasz Z, Toubi E, Giacomelli R (2019) Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases. Autoimmun Rev 18(10):102369","journal-title":"Autoimmun Rev"},{"issue":"3","key":"3017_CR52","doi-asserted-by":"crossref","first-page":"E400","DOI":"10.1210\/jc.2011-2697","volume":"97","author":"L van Steensel","year":"2012","unstructured":"van Steensel L, Paridaens D, van Meurs M, van Hagen PM, van den Bosch WA, Kuijpers RW, Drexhage HA, Hooijkaas H, Dik WA (2012) Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves\u2019 ophthalmopathy. J Clin Endocrinol Metab 97(3):E400\u2013E408","journal-title":"J Clin Endocrinol Metab"},{"key":"3017_CR53","first-page":"46","volume":"108","author":"DO Kikkawa","year":"2010","unstructured":"Kikkawa DO (2010) Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis). Trans Am Ophthalmol Soc 108:46\u201361","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"8","key":"3017_CR54","doi-asserted-by":"crossref","first-page":"100699","DOI":"10.1016\/j.xcrm.2022.100699","volume":"3","author":"Z Li","year":"2022","unstructured":"Li Z, Wang M, Tan J, Zhu L, Zeng P, Chen X, Xie L, Duan R, Chen B, Tao T, Wang R, Wang X, Su W (2022) Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy. Cell Rep Med 3(8):100699","journal-title":"Cell Rep Med"},{"issue":"8","key":"3017_CR55","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1210\/endo.140.8.6881","volume":"140","author":"TJ Smith","year":"1999","unstructured":"Smith TJ, Parikh SJ (1999) HMC-1 mast cells activate human orbital fibroblasts in coculture: evidence for up-regulation of prostaglandin E2 and hyaluronan synthesis. Endocrinology 140(8):3518\u20133525","journal-title":"Endocrinology"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03017-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03017-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03017-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:44:06Z","timestamp":1741880646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03017-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3017"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03017-9","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"38"}}